Pallett, S. J. C.
Denny, S. J.
Patel, A.
Charani, E.
Mughal, N.
Stebbing, J.
Davies, G. W.
Moore, L. S. P.
Funding for this research was provided by:
NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance
Article History
Received: 5 May 2020
Accepted: 23 February 2021
First Online: 12 March 2021
Competing interests
: LSPM has consulted and/or received speaker fees from bioMerieux (2013–2020), Pfizer (2018–2020), Eumedica (2016–2020), Umovis Lab (2020), DNAelectronics (2015–18), and Dairy Crest (2017–2018), received research grants from the National Institute for Health Research (2013–2019), and CW + Charity (2018–2020). NM has received speaker fees from Beyer (2016) and Pfizer (2019–2020) and received educational support from Eumedica (2016) and Baxter (2017). JS, the Editor-in-Chief of Oncogene has sat on Scientific Advisory Boards for Celltrion, Singapore Biotech, Vor Biopharma, Vaccitech, Heat Biologics, Lilly, Greenmantle and Benevolent AI, has consulted with Lansdowne partners and Vitruvian. He sits on the Board of Directors for BB Biotech Healthcare Trust. SJCP has received a research grant from the Scientific Exploration Society. EC has received speaker fees from bioMerieux (2019). The other authors declare no competing interests.